Effective working groups can continue their traditions through surprising changes in location, membership, etc.
I contend that the outcome of a given treatment episode is often determined right at the outset, based on why the clients is in treatment in the first place.
The physician, meanwhile, depends on the information provided by medical science, usually in the form of materials from the pharma firm that markets the product.
If the dose is in fact subtherapeutic, then what causes the effects so enthusiastically reported by the user?
Suppose we could develop cognitive techniques and train the patient to use them whenever symptoms reappeared?
The relative importance of set and setting suggests that the environment in an LSD experience should be carefully controlled.
In fact, it’s often difficult to convince the trauma patient to seek treatment, in part because of fear of having to re-experience the event.
The field is getting accustomed to patients arriving in addiction treatment complaining of problems with prescription opioids, stimulants, sedatives, etc, while actively enrolled in medical cannabis programs.
“It’s too much like doing your taxes,” was her verdict. That’s probably the worst thing I’ve heard anyone say about psychotherapy.